Deployment of drug-eluting stents for isolated proximal LAD disease is associated with lower major adverse cardiac events (MACE) and no increase in stent thrombosis when compared to bare metal stents: a 5 year observational cohort study
Catheterization and Cardiovascular Interventions, 06/29/2012
Jones DA et al. – When treating proximal LAD disease, use of drug eluting stents (DES) was associated with a lower MACE rate than BMS, with no differences in the incidence of stent thrombosis, myocardial infarction or 5 year all cause mortality. This data suggests that despite the adverse prognostic correlates of proximal LAD disease, DES deployment in this location is both safe and clinically more effective than BMS.